이비인후과 기기 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2024-2032년)

The Global ENT Devices Market was worth USD 20.8 billion in 2023 and is projected to experience 6.3% CAGR throughout the forecast period. This growth can be attributed to several factors, including the rising number of surgical and diagnostic procedures, a significant increase in the prevalence of ENT disorders, and proactive government initiatives aimed at raising awareness about these conditions. One of the key drivers of market expansion is the growing recognition and uptake of hearing aids and cochlear implants. As populations age, the incidence of hearing loss has surged, resulting in heightened demand for these assistive devices.

Technological advancements, such as the development of smart hearing aids equipped with Bluetooth connection and noise-cancellation features, have further enriched the user experience and stimulated growth in this sector. Based on product type, the hearing aids segment represented a significant portion of the market, accounting for 37.2% of the total share in 2023. The increasing awareness of hearing loss's impact on overall quality of life is motivating more individuals to pursue treatment. Furthermore, government policies and initiatives designed to enhance access to hearing aids, particularly in developing regions, are playing a pivotal role in fostering market growth. In terms of end users, the ENT devices market is segmented into hospitals, ambulatory surgical centers, ENT clinics, and home care.

The hospital segment dominated the market with a share of 36% in 2023, reflecting the rising utilization of ENT diagnostic and surgical devices in these settings. Recent technological advancements have yielded precise and effective diagnostic tools, such as high-definition endoscopes and advanced imaging systems. These innovations have improved the accuracy of diagnoses and the efficacy of treatment planning. The growing incidence of ENT disorders, including chronic sinusitis, sleep apnea, and hearing loss, is further driving the demand for these advanced diagnostics and surgical solutions.

In North America, the ENT devices market reached USD 8.1 billion in 2023 and is anticipated to grow at a CAGR of 5.2% over the analysis period. The strong demand for ENT devices in this region is fueled by a high prevalence of disorders, a robust healthcare infrastructure, and a commitment to technological innovation. Additionally, an aging population and heightened awareness regarding ENT health are contributing factors. The continuous approval of new products and the introduction of advanced technologies are also expected to positively influence market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of ENT disorders globally
    • 3.2.1.2 Increasing geriatric population
    • 3.2.1.3 Technological advancements in the ENT devices
    • 3.2.1.4 Rising demand for minimally invasive ENT procedures
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High procedure and instruments cost
    • 3.2.2.2 Social stigma across the globe
• 3.3 Growth potential analysis
• 3.4 Reimbursement scenario
  • 3.4.1 U.S.
  • 3.4.2 Europe
• 3.5 Technological landscape
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 Europe
• 3.7 Future market trends
• 3.8 Value-chain analysis
• 3.9 Gap analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Diagnostic ear, nose, and throat (ENT) devices
  • 5.2.1 Rigid endoscopes
    • 5.2.1.1 Rhinoscopes
    • 5.2.1.2 Laryngoscopes
    • 5.2.1.3 Otological endoscopes
  • 5.2.2 Flexible endoscopes
  • 5.2.3 Robot assisted endoscopes
  • 5.2.4 Hearing screening devices
• 5.3 Surgical ear, nose, and throat (ENT) devices
  • 5.3.1 Radiofrequency handpieces
  • 5.3.2 Powered surgical instruments
  • 5.3.3 Otological drill burrs
  • 5.3.4 ENT hand instruments
  • 5.3.5 Tympanostomy tubes
  • 5.3.6 Sinus dilation devices
  • 5.3.7 Nasal packing devices
• 5.4 Hearing aids
  • 5.4.1 Behind-the-ear (BTE)
  • 5.4.2 Completely-in-the-canal/Invisible-in-canal (CIC/IIC)
  • 5.4.3 In-the-canal [In-the-canal (ITC)]
  • 5.4.4 In-the-ear (ITE)
  • 5.4.5 Receiver in the ear/Receiver in canal (RITE/RIC)
• 5.5 Hearing implants
  • 5.5.1 Auditory brainstem implants
  • 5.5.2 Cochlear implants
  • 5.5.3 Middle ear implants
  • 5.5.4 Bone anchored hearing systems
• 5.6 Voice prosthesis devices
• 5.7 Nasal splints
  • 5.7.1 Internal nasal splints
  • 5.7.2 External nasal splints

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Ambulatory surgical centers
• 6.4 ENT clinics
• 6.5 Homecare

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE
  • 7.6.4 Turkey

Chapter 8 Company Profiles

• 8.1 Atos Medical
• 8.2 Boston Scientific Corporation
• 8.3 Cochlear
• 8.4 DeSoutter Medical
• 8.5 Johnson & Johnson
• 8.6 Lumenis
• 8.7 Medtronic
• 8.8 Meril Life Sciences
• 8.9 Narang Medical
• 8.10 Nouvag
• 8.11 Olympus Corporation
• 8.12 Smith & Nephew
• 8.13 Sonova Group
• 8.14 Stryker Corporation
• 8.15 Vega Medical
• 8.16 Welch Allyn
• 8.17 WestCMR
• 8.18 Zimmer Biomet